These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 6142954)

  • 1. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
    J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
    Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of alpha 1-adrenoceptors in rat renal cortex: comparison of [3H]-prazosin binding with the alpha 1-adrenoceptor modulating gluconeogenesis under physiological conditions.
    McPherson GA; Summers RJ
    Br J Pharmacol; 1982 Sep; 77(1):177-84. PubMed ID: 6127133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S66-75. PubMed ID: 2414598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study.
    Offermeier J; van Rooyen JM; Rossouw J
    S Afr Med J; 1986 Feb; 69(4):234-6. PubMed ID: 2869590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
    Büscher R; Heeks C; Taguchi K; Michel MC
    Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-adrenoceptor-mediated vasoconstriction in vivo to enantiomers of SK & F 89748-A.
    Timmermans PB; Matthews WD; Demarinis RM; Hieble JP; Mathy MJ; Doods HN; Thoolen MJ; De Jonge A; Wilffert B; Van Zwieten PA
    Eur J Pharmacol; 1984 May; 101(1-2):45-55. PubMed ID: 6146531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of alpha-adrenoceptor populations. Quantitative relationships between cardiovascular effects initiated at central and peripheral alpha-adrenoceptors.
    Timmermans PB; de Jonge A; van Meel JC; Slothorst-Grisdijk FP; Lam E; van Zwieten PA
    J Med Chem; 1981 May; 24(5):502-7. PubMed ID: 6264080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
    Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE
    Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Displacement by alpha-adrenergic agonists and antagonists of 3H-prazosin bound to the alpha-adrenoceptors of the dog aorta and the rat brain.
    Nagatoma T; Tsuchihashi H; Sasaki S; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1985 Feb; 37(2):181-7. PubMed ID: 2860265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the alpha 2B-adrenoceptor subtype.
    Gobbi M; Frittoli E; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):382-6. PubMed ID: 1979424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.
    Bobik A
    Life Sci; 1982 Jan; 30(3):219-28. PubMed ID: 6122151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity of different alpha 1-agonists and antagonists for the alpha 1-adrenoceptors of rabbit and rat liver membranes.
    Taddei C; Poggesi E; Leonardi A; Testa R
    Life Sci; 1993; 53(12):PL177-81. PubMed ID: 8103184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain.
    Miach PJ; Dausse JP; Cardot A; Meyer P
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):23-6. PubMed ID: 6248797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.